Drug Database
Back to search

Italy· 044887065

UPTRAVI*60 cpr rivestite 800 mcg

A selexipag product containing selexipag, registered in Italy by JANSSEN CILAG INTERNAT.N.V., on the national reimbursement list. The same ATC class is registered in 13 of our 19 countries.

Reimbursed in Italy (AIFA class A)ATC B01AC27

Checked against the register on

Informational only — not a medical device.

SOURCE REGISTER · ITPublic registernormalisedUPTRAVI*60 cpr rivestite 800 mcgATCB01AC27REGISTER NO.044887065PACKS LISTED1CHECKEDJune 4, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about selexipagAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Selexipag is registered in 13 of 19 countries.

Countries holding a registration under ATC B01AC27 (selexipag), each read from that country’s own register.

  • This record: Italy
  • 8 of them publish a price we can compare per daily dose
Search selexipag products by name

Selexipag · ATC B01AC27

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of selexipag costs, country by country.

Normalised to the WHO defined daily dose (1.8 mg), the median price runs from $809.99 in Switzerland to $1232.99 in Italy — a ×1.5 gap.

  • Italy: $1232.99 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Selexipag · price per daily dose (1.8 mg)

USD · FX 28 Sept 2026

  • IT Italy$1232.99
  • CH Switzerland$809.99
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Active substance
Selexipag
Manufacturer
JANSSEN CILAG INTERNAT.N.V.
Country
Italy (IT)
ATC code
B01AC27
ATC class
Selexipag
Defined daily dose
1.8 mg, O
Reimbursed
Yes
Last checked
June 4, 2026

Packs & prices · 1

1 priced
  • aic
    044887065
    UPTRAVI*60 cpr rivestite 800 mcg
    EUR 7220

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

237 interactions on record for selexipag.

Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check selexipag against other medicinesHow interaction checks work

Selexipag · interactions on record

237 records

  • 1 severe
  • 232 moderate
  • 4 minor

Most severe, free to view

  • GemfibrozilC10AB04severe
  • PapaverineA03AD01moderate
  • MannitolA06AD16moderate
  • GlycerolA06AX01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Selexipag in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All selexipag products

Authorised across Europe · EMA

The same active substance is authorised in 18 EEA countries. Names it is sold under:

  • Austria · Selexipag Ratiopharm
  • Cyprus · Selexipag Accord
  • Denmark · Selexipag Accord, Selexipag Stada
  • Estonia · Selexipag Stada
  • Spain · Selexipag Accord, Selexipag Stada
  • Greece · Xipeno
  • Croatia · Seleksipag Accord
  • Ireland · Selexipag Accord, Selexipag Clonmel
  • Iceland · Selexipag Stada, Uptravi
  • Liechtenstein · Uptravi
  • Lithuania · Selexipag Stada
  • Latvia · Selexipag Stada
  • Malta · Selexipag Clonmel
  • Netherlands · Seleksipag Accord, Selexipag Abdi
  • Norway · Selexipag Accord, Selexipag Stada
  • Poland · Selexipag, Selexipag Accord
  • Portugal · Selexipag Accord, Selexipag Teva
  • Sweden · Selexipag, Selexipag Accord

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b1eb6167-78ae-4d86-ba66-4480bad27aad
GET /v1/drugs/b1eb6167-78ae-4d86-ba66-4480bad27aad?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "price": 7220,
  "source": "aifa",
  "currency": "EUR",
  "strength": "SELEXIPAG 800MCG 60 UNITA' USO ORALE",
  "substance": "Selexipag",
  "equivalence_group": "JKM",
  "transparency_flag": null
}
API referenceMCP serverPlans

See everything about selexipag.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console